Disease Progression in Multiple System Atrophy: The Value of Clinical Cohorts with Long Follow-Up

Mov Disord. 2023 Aug;38(8):1567-1569. doi: 10.1002/mds.29534.

Tiphaine Saulnier¹, Margherita Fabbri^{2

3}, Anne Pavy-Le Traon^{2

3}, Mélanie Le Goff¹, Catherine Helmer^{1

4}, Patrice Péran⁵, Wassilios G Meissner^{6

7

8}, Olivier Rascol^{2

3}, Alexandra Foubert-Samier^{1

4

6

7}, Cécile Proust-Lima^{1

4}

¹ Univ. Bordeaux, Bordeaux Population Health Research Center,Inserm U1219, Bordeaux, France.
² MSA French Reference Center, Univ. Hospital Toulouse, Toulouse, France.
³ Univ. Toulouse, CIC-1436, Departments of Clinical Pharmacology and Neurosciences, NeuroToul COEN Center, NS-Park/FCRIN Network, Toulouse University Hospital,InsermU1048/1214, Toulouse, France.
⁴ Inserm,CIC1401-EC, Bordeaux, France.
⁵ ToNIC, Toulouse NeuroImaging Center, Univ Toulouse, Inserm, UPS, Toulouse, France.
⁶ CHU Bordeaux, Service de Neurologie des Maladies Neurodégénératives, IMNc,CRMRAMS, NS-Park/FCRIN Network, Bordeaux, France.
⁷ Univ. Bordeaux, CNRS, IMN, Bordeaux, France.
⁸ Department Medicine, University of Otago, Christchurch, and New Zealand Brain Research Institute, Christchurch, New Zealand.

No abstract available

Publication types